Haruna Kawano

Tokyo, 1138431, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 33 publications

Clinical rather than genetic factors predict hepatic cyst burden and growth in autosomal dominant polycystic kidney disease: a cohort study of 332 genotyped patients.

Clinical rather than genetic factors predict hepatic cyst burden and growth in autosomal dominant polycystic kidney disease: a cohort study of 332 genotyped patients.

Journal: Clinical and experimental nephrology

Published: March 10, 2026

Reduction of urothelial umbrella cells and impairment of barrier function in neurogenic bladder: identification of influencing factors.

Reduction of urothelial umbrella cells and impairment of barrier function in neurogenic bladder: identification of influencing factors.

Journal: Journal of pediatric surgery

Published: February 26, 2026

A machine-learning approach to predict additional treatment after Bacillus Calmette-Guérin induction in non-muscle-invasive bladder cancer.

A machine-learning approach to predict additional treatment after Bacillus Calmette-Guérin induction in non-muscle-invasive bladder cancer.

Journal: Scientific reports

Published: February 18, 2026

Correction to: Kidney Week 2025 Abstract Three-Month Interim Analysis of Ketogenic Metabolic Therapy in Japanese Patients with ADPKD SA-PO0579.

Correction to: Kidney Week 2025 Abstract Three-Month Interim Analysis of Ketogenic Metabolic Therapy in Japanese Patients with ADPKD SA-PO0579.

Journal: Journal of the American Society of Nephrology : JASN

Published: January 21, 2026

Local radiotherapy for cancer patients is associated with mosaic loss of chromosome Y, a hallmark of male aging.

Local radiotherapy for cancer patients is associated with mosaic loss of chromosome Y, a hallmark of male aging.

Journal: npj aging

Published: April 28, 2025

Development and validation of a simplified CT volumetry for estimating total liver volume in patients with autosomal dominant polycystic kidney and liver disease.

Development and validation of a simplified CT volumetry for estimating total liver volume in patients with autosomal dominant polycystic kidney and liver disease.

Journal: Clinical and experimental nephrology

Published: November 18, 2024

Kidney Function Trajectories with Tolvaptan in ADPKD Patients with CKD-G5.

Kidney Function Trajectories with Tolvaptan in ADPKD Patients with CKD-G5.

Journal: Kidney international reports

Published: October 26, 2024

Protocol for the nationwide registry of patients with polycystic kidney disease: japanese national registry of PKD (JRP).

Protocol for the nationwide registry of patients with polycystic kidney disease: japanese national registry of PKD (JRP).

Journal: Clinical and experimental nephrology

Published: February 19, 2024

Long-Term Effects of Tolvaptan in Autosomal Dominant Polycystic Kidney Disease: Predictors of Treatment Response and Safety over 6 Years of Continuous Therapy.

Long-Term Effects of Tolvaptan in Autosomal Dominant Polycystic Kidney Disease: Predictors of Treatment Response and Safety over 6 Years of Continuous Therapy.

Journal: International journal of molecular sciences

Published: January 12, 2024

Correction to: Public support for patients with intractable diseases in Japan: impact on clinical indicators from nationwide registries in patients with autosomal dominant polycystic kidney disease.

Correction to: Public support for patients with intractable diseases in Japan: impact on clinical indicators from nationwide registries in patients with autosomal dominant polycystic kidney disease.

Journal: Clinical and experimental nephrology

Published: November 04, 2023

Retrospective observational study of a novel smartphone app on the management of patients with mild cognitive impairment or mild dementia.

Retrospective observational study of a novel smartphone app on the management of patients with mild cognitive impairment or mild dementia.

Journal: Frontiers in digital health

Published: June 20, 2023

Chapter 1: Evaluation of kidney function in patients undergoing anticancer drug therapy, from clinical practice guidelines for the management of kidney injury during anticancer drug therapy 2022.

Chapter 1: Evaluation of kidney function in patients undergoing anticancer drug therapy, from clinical practice guidelines for the management of kidney injury during anticancer drug therapy 2022.

Journal: International journal of clinical oncology

Published: May 22, 2023

Showing 1-12 of 33

Last Updated: 09/26/2026